Rundo Pharmaceutical R&D
PrivateLast Round
Series C
May 6, 2019
Total Funding Raised
$14.85M
Company Overview
Rundo Pharmaceutical R&D operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series C round in May 2019.
Rundo Pharmaceutical R&D (Shanghai) Co., Ltd. is a contract research organization (CRO) that provides one-stop clinical trial management services for pharmaceutical and biotech companies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Drug Discovery, Compliance
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rundo Pharmaceutical R&D Comparables
Compare Rundo Pharmaceutical R&D with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bestudy (Shanghai) Medical Technology Co., Ltd. | 88% | |
| Beijing Highthink Pharmaceutical Technology Service Co., Ltd. | 88% | |
| R&G PharmaStudies Co., Ltd. | 84% |
For institutional investors. Book with your work email.
Rundo Pharmaceutical R&D Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 6, 2019 | ||||
| Series B | May 1, 2017 | ||||
| Series A | Mar 1, 2012 | ||||
| Angel | Mar 1, 2007 |
For institutional investors. Book with your work email.
Rundo Pharmaceutical R&D Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series B |
| Welight Capital | Series C |
| Sunshine Riverhead Capital Investment Management Co., Ltd. | Series C |
| Gaozheng Capital | Series A |
| Shenzhen Capital Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2012
Raised Series A with Shenzhen Capital Group and Gaozheng Capital.
For institutional investors. Book with your work email.
Rundo Pharmaceutical R&D Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rundo Pharmaceutical R&D's valuation, stock price, and market status.
Is Rundo Pharmaceutical R&D a public or private company?
Rundo Pharmaceutical R&D is a private company.
What is the current stock price of Rundo Pharmaceutical R&D?
Rundo Pharmaceutical R&D is a private company, so its shares have no public market price. Caplight tracks Rundo Pharmaceutical R&D's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rundo Pharmaceutical R&D worth (valuation)?
Valuation information for Rundo Pharmaceutical R&D is not publicly available.
Can I buy Rundo Pharmaceutical R&D stock?
Rundo Pharmaceutical R&D shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rundo Pharmaceutical R&D's last funding round?
Rundo Pharmaceutical R&D's most recent funding round was Series C on May 6, 2019.
Who are the main investors in Rundo Pharmaceutical R&D?
Key investors in Rundo Pharmaceutical R&D include HighLight Capital, Sunshine Riverhead Capital Investment Management Co., Ltd..
Will Rundo Pharmaceutical R&D IPO soon?
No public IPO plans have been announced for Rundo Pharmaceutical R&D.
How can I track Rundo Pharmaceutical R&D secondary market activity?
Caplight tracks bids, offers, and trades in Rundo Pharmaceutical R&D's shares on secondary markets.